Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
ZYME compared with ANAB: revenue, margins and what each company keeps, and the suppliers and customers both name
ZYME
Zymeworks Inc.
Change
Mkt cap
Revenue
Revenue
ANAB
Anaptysbio, Inc
Change
Mkt cap
Revenue
Revenue
vs
Compare
ZYME
Zymeworks Inc.
vs
ANAB
Anaptysbio, Inc
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
ZYME, solid
ANAB, dashed
Supply-chain overlap
Revenue flow
ZYME: latest quarter is a loss; flow not drawable. ANAB: latest quarter is a loss; flow not drawable.
Method
›
ZYME
Zymeworks Inc.
Change
28.99
▲
+1.33%
· post 28.99
Mkt cap
$2.1B
Revenue
$5M
Q2 FY26
Revenue
$106M
FY25
ANAB
Anaptysbio, Inc
Change
48.04
▼
−0.51%
· post 47.31
Closed
Nov 2 '26
Mkt cap
$1.4B
Revenue
$26M
Q1 FY26
Revenue
$235M
FY25
vs
Compare
Closed
Nov 2 '26
ZYME
Zymeworks Inc.
vs
ANAB
Anaptysbio, Inc
28.99
▲
+1.33%
post 28.99
Price
48.04
▼
−0.51%
post 47.31
$2.1B
Mkt cap
$1.4B
Q2 FY26
$5M
Revenue
$26M
Q1 FY26
FY25
$106M
Revenue
$235M
FY25
Change
Change
ZYME
28.99
▲
+1.33%
vs
ANAB
48.04
▼
−0.51%
Closed
Nov 2 '26
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only ZYME
11
JNJ
J&J
customer
BMY
Celgene (now BMS)
customer
JAZZ
Jazz Pharmaceuticals Ireland
customer
RPRX
Royalty Pharma
customer
7 more · ZYME chain
›
Shared
0
No shared counterparties.
Only ANAB
4
VNDA
Vanda Pharmaceuticals
customer
GSK
GSK
customer
—
DRI Healthcare Trust
unlisted
supplier
—
Sagard Healthcare Royalty Partners
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
unlisted
supplier